Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 11, 2020
Insights on the genetic features of endometrial pathogenic Escherichia coli strains from pyometra in companion animals: Improving the knowledge about pathogenesisC E Lopes, S De Carli, M N Weber, et al.
Genetics and Molecular Research : GMR|February 25, 2016
Vascular endothelial growth factor as an angiogenesis biomarker for the progression of autosomal dominant polycystic kidney diseaseD P Martins, M A Souza, M E Lopes Baitello, et al.
Frontiers in Sports and Active Living|April 27, 2026
The defensive playing style was associated with match-running performance and team success in the FIFA Women's 2023 World CupLuís Branquinho, Elias de França, Adriano Titton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 27, 2014
Antibody desensitization therapy in highly sensitized lung transplant candidatesL D Snyder, A L Gray, J M Reynolds, et al.
Nature|March 28, 2008
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat functionLiang Zhou, Jared E Lopes, Mark M W Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemiaDaniel E Lopes de Menezes, Jing Peng, Evelyn N Garrett, et al.
Clinical and Experimental Obstetrics & Gynecology|August 27, 2013
Placental and umbilical cord macroscopic changes associated with fetal and maternal events in the hypertensive disorders of pregnancyA K Marques Salge, R Maioni Xavier, W S Ramalho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivoArchie N Tse, Katherine G Rendahl, Tahir Sheikh, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeuticsYee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphomaDaniel E Lopes de Menezes, Kimberly Denis-Mize, Yan Tang, et al.
Pageof 15